Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

Clinical trial NCT06958432 · RECRUITING

Trial details

NCT number: NCT06958432
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Rectal Cancer Neoadjuvant Therapies Immune Checkpoint Therapy Radiotherapy

Start date: 2025-05-01
Primary completion: 2030-12-31
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.